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Actin-crosslinking proteins control actin filament networks and bundles and contribute 
to various cellular functions including regulation of cell migration, cell morphology, 
and endocytosis. Phosphatidylinositol 3-kinase-associated protein (PI3KAP)/XB130 
has been reported to be localized to actin filaments (F-actin) and required for cell 
migration in thyroid carcinoma cells. Here, we show a role for PI3KAP/XB130 as an 
actin-crosslinking protein. First, we found that the carboxyl terminal region of PI3KAP/
XB130 containing amino acid residues 830–840 was required and sufficient for localization 
to F-actin in NIH3T3 cells, and this region is directly bound to F-actin in vitro. Moreover, 
actin-crosslinking assay revealed that recombinant PI3KAP/XB130 crosslinked 
F-actin. In general, actin-crosslinking proteins often multimerize to assemble multiple 
actin-binding sites. We then investigated whether PI3KAP/XB130 could form a multimer. 
Blue native-PAGE analysis showed that recombinant PI3KAP/XB130 was detected at 
250–1200 kDa although the molecular mass was approximately 125 kDa, suggesting 
that PI3KAP/XB130 formed multimers. Furthermore, we found that the amino terminal 
40 amino acids were required for this multimerization by co-immunoprecipitation assay 
in HEK293T cells. Deletion mutants of PI3KAP/XB130 lacking the actin-binding region 
or the multimerizing region did not crosslink actin filaments, indicating that actin binding 
and multimerization of PI3KAP/XB130 were necessary to crosslink F-actin. Finally, we 
examined roles of PI3KAP/XB130 on endocytosis, an actin-related biological process. 
Overexpression of PI3KAP/XB130 enhanced dextran uptake in HEK 293 cells. However, 
most of the cells transfected with the deletion mutant lacking the actin-binding region 
incorporated dextran to a similar extent as control cells. Taken together, these results 
demonstrate that PI3KAP/XB130 crosslinks F-actin through both its actin-binding region 
and multimerizing region and plays an important role in endocytosis.
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inTrODUcTiOn
Actin is a highly conserved essential component of the cytoskel-
eton that generates forces to drive cell motility, cell division, and 
cell adhesion, maintains cell morphology and polarity, and func-
tions in endocytosis and vesicular trafficking (1). These processes 
are indispensable for a variety of biological processes such as 
development of endocrine tissues, maintenance of cell functions, 
synthesis and secretion of hormones in endocrine cells (2–4), 
and macropinocytosis and metastasis in cancer cells (5, 6). Actin 
filaments are constantly remodeled through polymerization of 
actin monomers into filaments and their subsequent organiza-
tion into functional higher-order structures. The remodeling of 
the actin cytoskeleton is regulated by more than 100 different 
actin-binding proteins, and actin-crosslinking proteins regulate 
the organization of actin filament networks and bundles and 
contribute to the development of specialized cellular structures 
including filopodia, lamellipodia, and stress fibers (7).
Actin filament-associated protein (AFAP) family of proteins 
consists of AFAP-110, AFAP1-like1 (AFAP1L1), and phosphati-
dylinositol 3-kinase-associated protein (PI3KAP)/XB130 (8–12). 
Among AFAP family members, AFAP-110 was first reported to 
bind to and crosslink actin filaments (13, 14). By these activities, 
AFAP-110 modulates changes in actin filament integrity (15). 
The actin-binding domain (ABD) of AFAP-110 is conserved in 
AFAP1L1, which has also been reported to be localized to the 
actin-based structure, invadosome (10). In contrast to these two 
AFAP family members, the ABD is not conserved in PI3KAP/
XB130. Nevertheless, it has been reported that PI3KAP/XB130 
is localized to cortical actin structures including lamellipodia 
(16, 17). These results suggest that PI3KAP/XB130 controls organi-
zation of actin filaments through novel mechanisms distinct from 
other AFAP family members.
We have been studying molecular mechanisms for the signal-
ing crosstalk between insulin-like growth factors (IGF) and tropic 
hormones in endocrine cells. In the course of our study, we found 
that expression of PI3KAP/XB130 was induced in response to 
thyroid-stimulating hormone (TSH) in the thyroid cells and in the 
thyroid gland, this increase was required for signaling  crosstalk 
with IGF leading to synergistic cell proliferation (12). Similar syn-
ergistic effects of IGF and tropic hormones are observed in vari-
ous other endocrine tissues, such as the adrenal gland, testis, and 
ovary, and in these tissues, the signaling crosstalk is indispensable 
for the cells to proliferate, differentiate, and maintain their func-
tions (18–22). By contrast, expression of PI3KAP/XB130 has been 
reported in endocrine cancers such as thyroid cancer cells, and 
PI3KAP/XB130 knockdown inhibits cell proliferation, survival, 
migration, and invasion in these cell types (16, 23–25). These 
findings indicate a possibility that PI3KAP/XB130 plays impor-
tant roles in endocrine tissues and endocrine cancers. PI3KAP/
XB130 is considered to function as an adaptor protein, based on 
the molecular structures that can interact with other molecules. 
These structures include two PH domains, a coiled-coil domain 
and several binding motifs recognized by SH2 or SH3 domains. 
Indeed, PI3KAP/XB130 is tyrosine-phosphorylated by activation 
of cAMP pathways or by overexpression of c-Src or RET/PTC 
tyrosine kinase and thereby interacts with PI 3-kinase, which is 
likely to mediate signal transduction for cell proliferation (11, 12, 
23–27). However, it remains unclear, so far, whether PI3KAP/
XB130 interacts with actin itself or actin-binding proteins.
This study was undertaken to elucidate molecular mechanisms 
by which PI3KAP/XB130 regulates the organization of actin fila-
ments. In this study, we demonstrate that PI3KAP/XB130 binds 
to actin filaments via a novel actin-binding region different from 
the ABD of AFAP-110 or AFAP1L1. Moreover, we also show that 
PI3KAP/XB130 forms multimers, and multimerization of this 
protein can lead to crosslinking of actin filaments. To uncover 
a novel function of this protein in an actin-related process, we 
further verified whether PI3KAP/XB130 is involved in regulation 
of endocytosis in HEK 293 cells. Here, we propose a novel role 
for PI3KAP/XB130 as an actin-crosslinking protein, and this 
may link actin localization of PI3KAP/XB130 and regulation of 
endocytosis mediated by this protein.
MaTerials anD MeThODs
Materials
Dulbecco’s Modified Eagle’s medium (DMEM), phosphate-
buffered saline (PBS), and Hanks’ balanced salt solution were 
obtained from Nissui (Tokyo, Japan). Fetal bovine serum (FBS) 
and calf serum (CS) were obtained from JRH Bioscience (Tokyo, 
Japan). Anti-Myc monoclonal antibody (9E10) was purchased 
from Millipore (Billerica, MA, USA). Anti-FLAG M2 antibody 
and anti-α-tubulin antibody (B-5-1-2) were obtained from 
Sigma-Aldrich (St. Louis, MO, USA). Anti-GFP monoclonal 
antibody (B-2) was purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). Anti-PI3KAP/XB130 antibody was 
raised in our laboratory as previously described (12). Alexa Fluor 
488-conjugated anti-mouse IgG antibody was from Invitrogen 
(Carlsbad, CA, USA). Horseradish peroxidase (HRP)-linked anti-
mouse IgG antibody and HRP-linked anti-rabbit IgG antibody 
were purchased from GE Healthcare (Buckinghamshire, UK). 
Other chemicals were of reagent grade available commercially.
cell culture
NIH3T3 cells were purchased from Health Science Research 
Resources Bank (Osaka, Japan). HEK293T cells were a kind gift 
from Dr. Kunio Shiota (The University of Tokyo, Tokyo, Japan). 
HEK293 cells were kindly provided by Dr. Koichi Suzuki (Teikyo 
University, Tokyo, Japan). NIH3T3 cells, HEK293T cells, and 
HEK293 cells were cultured in DMEM containing 1  mg/ml 
NaHCO3, 50 IU/ml penicillin, 50 μg/ml streptomycin, 0.5 μg/ml 
amphotericin B, and 100 μg/ml kanamycin supplemented with 
10% FBS (NIH3T3 cells and HEK293 cells) or 10% CS (HEK293T 
cells). FRTL-5 rat thyroid follicular cells (28) were kindly pro-
vided by the late Dr. Leonard Kohn (Ohio University and Edison 
Biotechnology Institute, Athens, OH, USA). FRTL-5 cells were 
cultured as previously described (12).
Plasmid construction
The mammalian expression plasmid pShuttle2-FLAG-PI3KAP/
XB130 was prepared as previously described (12), and pShuttle2-
myc-PI3KAP/XB130 for expressing N-terminally myc-tagged 
PI3KAP/XB130 was constructed by myc-tagged PI3KAP/XB130 
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into the pShuttle2 vector. pShuttle2 plasmids for expressing 
FLAG-tagged or myc-tagged PI3KAP/XB130 deletion mutants 
were constructed by cloning each deletion mutant into the pShut-
tle2 vector. pEGFP plasmids for expressing GFP-fused PI3KAP/
XB130 or its deletion mutants were constructed by cloning each 
fragment into the pEGFP-C1 vector (Clontech, Mountain View, 
CA, USA). pGEX vectors (GE Healthcare, Bukcinghamshire, 
UK) were used for expression of fusion proteins with GST 
in Escherichia coli. pGEX plasmids for expressing GST-fused 
PI3KAP/XB130 deletion mutants were constructed by cloning 
each deletion mutant into pGEX vectors.
Transfection of Plasmids and sirna
Transfection of plasmids into NIH3T3 cells or HEK293 cells 
was performed using Lipofectamine 2000 (NIH3T3 cells) or 
Lipofectamine LTX (HEK293 cells) according to the manufac-
turer’s protocol (Invitrogen). Transfection into HEK293T cells 
was carried out using a calcium phosphate precipitation method 
as previously described (29). Transfection of siRNA into FRTL-5 
cells was performed using Lipofectamine RNAiMax according 
to the manufacturer’s protocol (Invitrogen). Random control 
siRNA and PI3KAP/XB130-specific siRNA were purchased 
from RNAi Corp. (Tokyo, Japan). The sequences of the PI3KAP/
XB130 siRNA were 5′-CGGUCAAGUCUUCCAUAAAAC-3′ 
(sense strand) and 5′-UUUAUGGAAGACUUGACCGGA-3′ 
(antisense strand).
immunofluorescence analysis
NIH3T3 cells were transfected with myc-tagged PI3KAP/XB130 
or deletion mutants and then cultured in 10% FBS/DMEM over-
night. Cells were washed once with PBS, fixed with 4% paraform-
aldehyde in PBS (4% PFA/PBS) for 10 min, and permeabilized 
with 0.2% Triton X-100 in PBS for 5 min at room temperature. 
Cells were then washed with PBS and incubated with 3% bovine 
serum albumin (BSA) in PBS for 1 h at room temperature, and 
primary antibodies (anti-Myc 9E10, 1:200 dilution) were added 
for 1 h at room temperature. The samples were again washed with 
PBS, incubated with 40 μM phalloidin-TRITC, and a secondary 
antibody conjugated to Alexa Fluor 488 (1:1000 dilution) for 
1 h. The coverslips were washed again with PBS three times and 
then mounted in Vectashield for visualization using a confocal 
microscope Olympus FV500 (Olympus, Tokyo, Japan).
Purification of gsT Fusion Proteins
GST fusion proteins were prepared as described before (30). 
Briefly, pGEX plasmid was transformed into E. coli BL21 (DE3) 
pLysS. Expression of GST fusion proteins was induced by 1 mM 
Isopropyl β-d-thiogalactopyranoside (IPTG) overnight at 26°C. 
Cells were harvested and lysed by sonication three times for 
30 s on ice in PBS containing 1% Triton X-100, 100 kallikrein-
inactivating (KI) U/ml aprotinin, 20 μg/ml phenylmethylsulfonyl 
fluoride (PMSF), 10  μg/ml leupeptin, and 5  μg/ml pepstatin. 
The lysates were centrifuged, and supernatant was added to the 
Glutathione–Sepharose column (GE Healthcare). After washing 
with PBS, the GST fusion proteins were eluted by elution buffer 
(50 mM Tris–HCl, pH 8.0, and 10 mM reduced glutathione). The 
eluates were subjected to protein assay using a protein assay kit 
(Bio-Rad, Hercules, CA, USA).
Purification of Flag-Tagged Proteins
HEK293T cells were transfected with pShuttle2 plasmids coding 
for FLAG-tagged PI3KAP/XB130 or its deletion mutants. Cells 
were cultured for 2 days and then lysed at 0°C in 500 μl lysis buffer 
containing 50  mM Tris–HCl (pH 7.4), 150  mM NaCl, 1  mM 
NaF, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 10% glycerol, 
500 μM Na3VO4, 100 KI U/ml aprotinin, 20 μg/ml PMSF, 10 μg/ml 
leupeptin, and 5 μg/ml pepstatin. The lysates were centrifuged at 
15,000 × g for 10 min at 4°C. The protein assay of the supernatant 
was performed using a protein assay kit (Bio-Rad). The cell lysates 
containing approximately 60  mg of protein were subjected to 
immunoprecipitation with anti-FLAG M2 antibody-conjugated 
agarose beads (Sigma-Aldrich). The immunoprecipitated FLAG-
tagged proteins were eluted with FLAG peptide (Sigma-Aldrich). 
Concentrations of the FLAG-tagged proteins were determined by 
SDS-PAGE followed by coomassie brilliant blue (CBB) staining 
using serially diluted BSA as a standard.
Blue native-Page
Blue native (BN)-PAGE analysis was performed as previously 
described (31) with slight modifications. Briefly, the FLAG-tagged 
PI3KAP/XB130 protein was prepared using anti-FLAG antibody 
as described above, and then, the protein samples were mixed 
with 1/20 volume of 5% CBB G-250. The samples were separated 
by NativePAGE Novex Bis-Tris Gels (Invitrogen) according to the 
manufacturer’s protocols.
immunoprecipitation and immunoblotting
Immunoprecipitation and Immunoblotting were performed 
according to standard procedures as described before (12). For 
immunoprecipitation of FLAG-tagged proteins, anti-FLAG M2 
antibody-conjugated agarose beads were used.
actin Filament Pelleting assay
Actin filament pelleting assay was carried out as previously 
described (32) with minor modifications. Actin monomers puri-
fied from rabbit skeletal muscle (AKL99) were purchased from 
Cytoskeleton, Inc. (Denver, CO, USA). F-actin was prepared by 
polymerizing actin monomers in F-buffer (50 mM KCl, 2 mM 
MgCl2, 0.2 mM ATP, and 0.2 mM DTT in 2M imidazole, pH 7.1) 
at room temperature for 30 min. Then F-actin (5 μM) was incu-
bated with GST-fused PI3KAP/XB130 deletion mutants (2.5 μM) 
for 30  min at room temperature. After ultracentrifugation at 
100,000 × g for 30 min at 4°C, the proteins in the supernatant 
or pellet fractions were analyzed by SDS-PAGE followed by CBB 
staining.
actin crosslinking/Bundling assay
Bovine serum albumin, FLAG-PI3KAP/XB130, or its deletion 
mutants (1 μM) were incubated with F-actin (5 μM) for 30 min at 
room temperature. Then the mixture was centrifuged at 8,000 × g 
for 20 min at 4°C. The supernatant or pellet fractions were ana-
lyzed by SDS-PAGE followed by CBB staining.
FigUre 1 | Pi3KaP/XB130 is localized to actin filaments. (a) The 
myc-tagged PI3KAP/XB130 deletion constructs used in the experiments are 
shown. The numbers indicate the amino acid residues from the N-terminal 
end of PI3KAP. PH, PH domain; CC, coiled-coil domain. (B) Myc-tagged 
PI3KAP/XB130 or deletion mutants were transfected into NIH3T3 cells. Fixed 
and permeabilized cells were stained with anti-myc antibody and TRITC-
labeled phalloidin. Myc-tagged proteins were visualized by Alexa488 in green 
in the confocal microscopy. F-actin was visualized in red.
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Dextran Uptake assay
HEK 293 cells seeded on coverslips were transfected with 
GFP-fused PI3KAP/XB130 or deletion mutants. Two days 
after transfection, the medium was replaced with 10% FBS/
DMEM containing 0.2 mg/ml dextran–Texas Red 70,000 MW 
(Thermo Fisher Scientific, Lafayette, CO, USA) and then cells 
were incubated at 37°C for 4  h. In the case for FRTL-5 cells, 
cells grown on coverslips were transfected with siRNA and 
cultured for 24  h. The cells were serum-starved for 24  h in 
Coon’s F-12 medium (Sigma-Aldrich) containing 0.1% bovine 
serum albumin (BSA/F-12 medium). Then the medium was 
replaced with BSA/F-12 medium containing 1 nM TSH. After 
treatment with TSH for 16  h, dextran–Texas Red was added 
at a final concentration of 0.2 mg/ml, and then, the cells were 
incubated for 8  h (TSH treatment time was 24  h in total). 
After incubation with dextran–Texas Red, HEK293 cells and 
FRTL-5 cells were washed three times with PBS and fixed with 
4% PFA/PBS for 10  min. After washing with PBS again, cells 
were stained with DAPI, and the coverslips were mounted 
in Vectashield for visualization using a confocal microscope. 
Immunofluorescence intensities of Texas Red were quantified 
and output as mean gray values using the ImageJ version 
1.49 program (http://rsb.info.nih.gov/ij/; National Institutes of 
Health, Bethesda, MD, USA). The intensities were measured in 
individual GFP-positive cells (HEK293 cells) or in individual 
colonies (FRTL-5 cells).
statistical analyses
Statistical analyses of data were performed by Student’s t-test or 
by one-way factorial ANOVA followed by Steel–Dwass post hoc 
multiple comparison test, as appropriate. p < 0.05 was considered 
statistically significant.
resUlTs
Pi3KaP/XB130 Was colocalized with actin 
Filaments through its c-Terminal region 
in cells
At first, we searched for putative actin-binding region(s) by ana-
lyzing colocalization of several PI3KAP/XB130 deletion mutants 
(Figure 1A) with actin filaments. We transfected NIH3T3 cells 
with myc-tagged PI3KAP/XB130 and found that PI3KAP/
XB130 was localized to actin stress fibers in NIH3T3 cells 
(Figure  1B). We further investigated localization of PI3KAP/
XB130 deletion mutants to stress fibers. As shown in Figure 1B, 
deletion mutants, in which C-terminal regions were deleted 
(1-510, 1-657, and 1-772), were diffused in the cytosol, and 
their localization did not correspond to actin filaments. These 
results indicated that a C-terminal sequence of approximately 
70 amino acids was required for localization to actin filaments. 
Consistently with these results, a deletion mutant consisting 
of C-terminal 69 amino acid residues (775–843) showed fila-
mentous patterns corresponding to actin filaments (Figure 1B). 
These results showed that a region responsible for PI3KAP/
XB130 colocalization with actin filaments existed within its 
C-terminal region 775-843.
Pi3KaP/XB130 Bound to actin Filaments 
through its c-Terminal region In Vitro
Colocalization of PI3KAP/XB130 with actin filaments prompted 
us to examine whether PI3KAP/XB130 can directly bind to 
actin filaments. To address this question, we performed an actin 
filament pelleting assay using recombinant PI3KAP/XB130 frag-
ments fused to GST (Figure 2A). In this in vitro assay, fragments 
that can bind to actin filaments will co-sediment with actin 
filaments by ultracentrifugation, but fragments that cannot bind 
will not. In control samples without actin, GST or GST-fused 
PI3KAP/XB130 fragments did not sediment by ultracentrifuga-
tion (Figure 2B), indicating that these recombinant proteins did 
FigUre 2 | Pi3KaP/XB130 binds to actin filaments. (a) The GST-fused PI3KAP/XB130 deletion constructs used in the experiments are shown. The numbers 
indicate the amino acid residues from the N-terminal end of PI3KAP/XB130. PH, PH domain; CC, coiled-coil domain. (B) Actin filaments polymerized in vitro were 
incubated with GST or GST-fused PI3KAP/XB130 deletion mutants. The mixture of actin filaments and GST-fusion proteins was subjected to ultracentrifugation, and 
the fractions of supernatant (S) and pellet (P) were separated by SDS-PAGE and then proteins were visualized by CBB staining. (c,D) Alignment of amino acid 
sequences of F-actin-binding region of PI3KAP/XB130 among mouse, rat, human, cattle, frog, and zebrafish (c) or among mouse PI3KAP/XB130, AFAP-110, and 
AFP1L1 (D). The asterisks indicate identical amino acid residues.
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FigUre 3 | Pi3KaP/XB130 crosslinks actin filaments. Actin filaments 
polymerized in vitro were incubated with BSA or FLAG-tagged recombinant 
PI3KAP/XB130. The mixture was subjected to low-speed centrifugation, and 
the fractions of supernatant (S) and pellet (P) were separated by SDS-PAGE 
and then proteins were visualized by CBB staining.
not self-aggregate to form pellets. When incubated with actin, 
a C-terminal fragment of PI3KAP/XB130 (amino acid residues 
511–843; GST-del1) cosedimented with actin filaments, while 
GST alone did not (Figure 2B), indicating that GST-del1 bound 
to actin filaments in vitro. In addition, deletion of the C-terminal 
70 amino acids from GST-del1 (GST-del2) abolished the 
cosedimentation, and these 70 amino acid residues (GST-del3) 
cosedimented with actin filaments. To further analyze minimal 
regions responsible for actin binding, we performed the pellet-
ing assay using shorter PI3KAP/XB130 fragments. As shown in 
Figure  2B, PI3KAP/XB130 fragments containing amino acid 
residues 830–840 (GST-del4, 5, 6, and 9) cosedimented with 
actin filaments. However, when this region was separated into 
two regions (GST-del7 and 8), cosedimentation of these frag-
ments was not observed. These results indicated that PI3KAP/
XB130 bound to actin filaments through amino acid residues 
830–840 and that this region needed to be intact. Furthermore, 
homology search analysis revealed that this region was highly 
conserved in many vertebrate species (Figure 2C). This region 
was also conserved in the C-terminal region of other AFAP fam-
ily members (Figure 2D), which was different from the known 
ABD in AFAP-110 and AFAP1L1.
Pi3KaP/XB130 crosslinked actin 
Filaments In Vitro
Some actin-binding proteins are known to crosslink actin fila-
ments to form actin meshwork or bundles. Therefore, we next 
tested whether PI3KAP/XB130 could crosslink actin filaments. 
To examine actin-crosslinking ability of PI3KAP/XB130, we per-
formed an in vitro crosslinking assay. In this assay, actin filaments 
are pelleted by low-speed centrifugation when they are mixed 
with an actin-crosslinking protein, although actin filaments alone 
remain in the supernatant. As shown in Figure  3, when actin 
was mixed with negative control BSA, actin remained in the 
supernatant fraction. By contrast, when actin was mixed with 
recombinant full-length PI3KAP/XB130, actin was detected in 
the pellet fraction. These results indicated that PI3KAP/XB130 
could crosslink actin filaments in vitro.
Pi3KaP/XB130 Formed Multimers 
through its n-Terminal region
In general, actin-crosslinking proteins that have one actin-binding 
site within a molecule need to form a dimer or a multimer to 
 crosslink actin filaments. Then, to investigate dimerization/multi-
merization of PI3KAP/XB130, we analyzed electrophoretic mobil-
ities of recombinant PI3KAP/XB130 under native conditions that 
maintain protein complexes using BN-PAGE. FLAG-PI3KAP/
XB130 was immuno-purified from HEK293T cells. Endogenous 
expression of PI3KAP/XB130 was not detected in HEK293T cells 
(data not shown). The recombinant FLAG-PI3KAP/XB130 was 
subjected to SDS-PAGE followed by CBB staining to confirm its 
purity. We did not detect any protein other than FLAG-PI3KAP/
XB130 at a CBB staining level (Figure 4A). The immuno-purified 
FLAG-PI3KAP/XB130 was subjected to BN-PAGE followed by 
immunoblotting using anti-FLAG antibody. PI3KAP/XB130 was 
detected at approximately 250 kDa, 500 kDa, and 900–1200 kDa 
in BN-PAGE (Figure 4B), even though PI3KAP/XB130 is usually 
detected at approximately 125 kDa in SDS-PAGE (Figure 4A). 
These results suggest that PI3KAP/XB130 formed multimers. To 
further confirm the multimerization, we co-transfected GFP-
PI3KAP/XB130 with FLAG-PI3KAP/XB130 into HEK293T cells 
and then analyzed their binding by co-immunoprecipitation 
assays. As shown in Figure  4D, GFP-PI3KAP/XB130 was co-
immunoprecipitated with FLAG-PI3KAPXB130, indicating 
that PI3KAPXB130 bound to itself in cells. Furthermore, we 
searched for region(s) necessary for the multimerization using 
several deletion mutants of PI3KAP/XB130 (Figure 4C). FLAG-
tagged deletion mutants that lack at least 40 amino acids in the 
N-terminus (amino acid residues 41–843, 122–843, 186–843, 
511–843, and 654–843) did not bind to GFP-PI3KAP/XB130, 
and deletion mutants containing N-terminal region (amino acid 
residues 1–675, 1–510, and 1–185) bound to it (Figure 4D). These 
results indicate that PI3KAP/XB130 formed multimers through 
its N-terminal region.
The Multimerizing region and  
actin-Binding region Were required for 
Pi3KaP/XB130 to crosslink actin 
Filaments
We next examined whether multimerization and actin binding 
of PI3KAP/XB130 could contribute to the actin crosslinking 
ability. We carried out the in  vitro crosslinking assay using 
7Yamanaka et al. Mechanisms for Actin Crosslinking by PI3KAP/XB130
Frontiers in Endocrinology | www.frontiersin.org July 2016 | Volume 7 | Article 89
FigUre 4 | Pi3KaP/XB130 forms a multimer. (a,B) FLAG-tagged recombinant PI3KAP/XB130 was purified from HEK293T cells and then subjected to 
SDS-PAGE (a) or BN-PAGE (B). (c) FLAG-tagged PI3KAP/XB130 deletion constructs used in the co-immunoprecipitation assays are shown. The numbers indicate 
the amino acid residues from the N-terminal end of PI3KAP/XB130. PH, PH domain; CC, coiled-coil domain. (D) GFP-PI3KAP/XB130 was co-transfected with full 
length or deletion mutant of FLAG-tagged PI3KAP/XB130 into HEK293T cells. The cell lysates were immunoprecipitated with anti-FLAG antibody, and then, the 
samples were subjected to immunoblotting with indicated antibodies.
PI3KAP/XB130 deletion mutants that lack the C-terminal 
actin-binding region (ΔABR) or the N-terminal 40 amino acids 
(ΔN40). We found that full-length PI3KAP/XB130 crosslinked 
actin filaments, but neither ΔABR nor ΔN40 showed the 
crosslinking ability (Figure 5). These results indicate that both 
of the C-terminal actin-binding region and the N-terminal 
multimerizing region were required for PI3KAP/XB130 to 
crosslink actin filaments.
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Pi3KaP/XB130 enhances endocytosis 
through the actin-Binding region  
at least in a Part
We further investigated a role of PI3KAP/XB130 in endocy-
tosis, an actin-related process. To examine this, we analyzed 
incorporation of fluorescence-labeled dextran as an index of 
endocytosis in HEK293 cells. As shown in Figure  6A, Texas 
Red-labeled dextran incorporated into cells was detected as small 
dots in GFP-transfected control cells and GFP-PI3KAP/XB130-
transfected cells (Figure 6A). To analyze dextran incorporation 
more quantitatively, we measured fluorescent intensities of Texas 
Red in GFP-positive cells (Figure  6B). This analysis revealed 
that the Texas Red intensities of the most abundant population 
were higher in GFP-PI3KAP/XB130-transfected cells than in 
GFP-transfected cells, and the difference of values between these 
two groups was statistically significant (Student’s t-test, p < 0.01). 
These results suggest that GFP-PI3KAP/XB130 enhanced endo-
cytosis. To further analyze effects of the ΔABR mutant, which 
lacks actin-binding region, we transfected cells with GFP-ΔABR 
and quantified amounts of incorporated dextran (Figures 6C,D). 
Unlike the case for GFP-PI3KAP/XB130, which enhanced dex-
tran uptake, most of the cells expressing GFP-ΔABR exhibited 
similar dextran uptake as GFP-expressing control cells. In addi-
tion, small number of cells showed relatively high fluorescent 
values of Texas Red (>10) even in GFP-ΔABR-transfected cells. 
Statistical analysis showed that the difference of the Texas Red 
values between GFP and GFP-PI3KAP/XB130 was statistically 
significant (ANOVA followed by Steel–Dwass post  hoc test, 
p < 0.05), and there were no statistically significant differences 
between GFP and GFP-ΔABR or between GFP-PI3KAP/XB130 
and GFP-ΔABR. These data suggest that, for PI3KAP/XB130 to 
control endocytosis properly, at least the actin-binding region 
is required. To examine a role of PI3KAP/XB130 in endocrine 
cells, we knocked down expression of this protein in a thyroid cell 
line FRTL-5 using siRNA and tested effects on dextran uptake. 
As previously described (12), PI3KAP/XB130 protein levels were 
increased in TSH-treated cells, and this effect was inhibited by 
transfection of siRNA against PI3KAP/XB130 (Figure 6E). The 
dextran uptake assay showed a tendency for dextran uptake to be 
inhibited in PI3KAP/XB130 knockdown cells (Figures 6F,G), but 
statistically, there were not significant differences between control 
cells and knockdown cells (Student’s t-test, p = 0.11).
DiscUssiOn
Actin filaments exist in cells as single filaments or as meshworks 
or bundles in which actin filaments are crosslinked by many 
kinds of actin-binding proteins. Together with initiation of 
de  novo actin polymerization, these crosslinked structures are 
required to realize the diversity of actin filament structures, lead-
ing to induction of cell migration, maintenance of cell shapes, 
endocytosis of macromolecules, and transport of intracellular 
vesicles (7, 33). Therefore, it is obvious that elucidating functions 
of  actin-crosslinking proteins is important to understand these 
actin-related biological processes. In this study, we demonstrated 
that PI3KAP/XB130 was a novel actin-crosslinking protein 
and characterized molecular mechanisms for PI3KAP/XB130-
mediated actin crosslinking. We found that the C-terminal region 
of PI3KAP/XB130 directly bound to actin filaments (Figure 2), 
and that PI3KAP/XB130 formed multimers via its N-terminal 
region (Figure  4). Furthermore, deletion mutants lacking the 
C-terminal region or the N-terminal region did not crosslink 
actin filaments (Figure  5). These results suggest that PI3KAP/
XB130, which multimerized through its N-terminal region, 
binds to actin filaments through its C-terminal region and then 
crosslinks the filaments.
Actin-binding domain of AFAP family protein was originally 
discovered in AFAP-110 (13). Among AFAP family members, 
this ABD is conserved in AFAP1L1. It has been reported that 
AFAP1L1 is also localized to actin filaments, suggesting that this 
ABD functions in AFAP1L1 as well (10). However, this ABD is 
not conserved in PI3KAP/XB130. Nevertheless, PI3KAP/XB130 
was localized to actin stress fibers (Figure 1). In contrast to these 
results, we and others have reported that PI3KAP/XB130 was 
localized to lamellipodia in thyroid carcinoma cells (16) and to 
lamellipodia-like cortical actin structures in non-transformed 
thyroid follicular cells (12), suggesting that intracellular localiza-
tion of this protein was not restricted to lamellipodia but was 
dependent on actin filament structures. These observations led 
us to speculate that PI3KAP/XB130 might possess a novel ABD. 
At first, we searched for a putative ABD in PI3KAP/XB130 by 
analyzing colocalization of PI3KAP/XB130 deletion mutants 
with actin stress fibers and found that the C-terminal region of 
PI3KAP/XB130 was necessary and sufficent to be localized to 
actin stress fibers. Lodyga et al. also reported that this carboxyl 
FigUre 5 | actin crosslinking by Pi3KaP/XB130 requires the 
dimerizing region and actin-binding region. Actin filaments polymerized 
in vitro were incubated with BSA, full-length PI3KAP/XB130 or the deletion 
mutants (ΔABR or ΔN40). The mixture was subjected to low-speed 
centrifugation, and the fractions of supernatant (S) and pellet (P) were 
separated by SDS-PAGE and then proteins were visualized by CBB staining.
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FigUre 6 | Pi3KaP/XB130 promotes dextran endocytosis through the actin-binding region. HEK293 cells were transfected with GFP, GFP-PI3KAP, or 
GFP-ΔABR in the presense of 10% FBS for 48 h (a–D). FRTL-5 cells were transfected with control or PI3KAP/XB130-specific siRNA, serum-starved for 24 h, and 
treated with 1 nM TSH for 24 h (e–g). The cells were incubated with 0.2 mg/ml dextran–Texas Red during the last 4 h [HEK293 cells; (a–D)] or 8 h [FRTL-5 cells; 
(F,g)]. After fixation and DAPI staining, dextran–Texas Red incorporated into cells was visualized by confocal microscopy. (a,c,F) Representative images of cells are 
shown. Gray scale images of Texas Red are indicated in upper panels and overlay images in lower panels (red, Texas Red; green, GFP; and blue, DAPI). (B,D,g) 
Amounts of dextran–Texas Red incorporated into cells were evaluated by the ImageJ software. The percentage of cells or colonies in each fraction of fluorescent 
intensity was indicated in histograms. The fluorescent values were analyzed by Student’s t-test [(B) n = 10–12, (g) n = 15] or by ANOVA followed by Steel–Dwass 
post hoc test [(D) n = 30–34]. (e) PI3KAP/XB130 protein levels were analyzed by immunoblotting.
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terminal region was required for localization to lamellipodial 
actin meshwork (16), supporting that this region was important 
for association of PI3KAP/XB130 with actin filaments. Therefore, 
we performed biochemical binding assays using C-terminal frag-
ment of PI3KAP/XB130 and demonstrated that the C-terminal 
10-amino acid sequence of PI3KAP/XB130 bound to actin 
filaments and this sequence was distinct from AFAP-110 ABD. 
Moreover, we could not find any similarity between this 10-amino 
acid sequence and other known ABDs, suggesting that this region 
functions as a novel ABD. Interestingly, this 10-amino acid 
sequence of PI3KAP/XB130 was conserved in the other AFAP 
family members, AFAP-110 and AFAP1L1 (Figure 2), indicating 
that this actin-binding region may contribute to actin binding of 
these proteins.
In addition to the C-terminal actin-binding domain in PI3KAP/
XB130, Lodyga et al. reported that N-terminal region of PI3KAP/
XB130 was also localized to lamellipodial actin meshwork using a 
human construct of PI3KAP/XB130 (16). By contrast, we did not 
find any colocalization with N-terminal region of PI3KAP/XB130 
using a mouse construct, suggesting species-specific mechanisms 
in localization to actin filaments. Lodyga et al. speculated that an 
actin-binding K/RYKXL motif, which resides in the N-terminal 
segment of human PI3KAP/XB130, might contribute to the 
localization by searching for actin-binding motifs using amino 
acid sequences. However, this motif is not conserved in mouse 
PI3KAP/XB130 that we used in this study (variant 1; GenBank 
Accession # NM_001177796), because the leucine residue within 
the motif is replaced with glutamine in the mouse sequence. 
Interestingly, there also exists a splice variant (variant 2; GenBank 
Accession # NM_001177797) that lacks the second exon in mouse 
PI3KAP/XB130 variant 1, and this alternative splicing yields the 
K/RYKXL motif in the N-terminus of the isoform produced from 
this splice variant. These differences in the actin-binding motif 
sequence in N-terminus suggest differential regulatory mecha-
nisms for localization to actin filaments among splice variants in 
PI3KAP/XB130, and the differential roles of these variants need 
to be further elucidated.
We further analyzed possible mechanisms for PI3KAP/
XB130 to regulate actin cytoskeletons and found that PI3KAP/
XB130 crosslinked actin filaments. Moreover, we also found that 
PI3KAP/XB130 formed a multimer. These results suggested that 
PI3KAP/XB130, which had one actin-binding site,  crosslinked 
actin filaments by making at least two actin-binding sites through 
multimerization. Our results that a multimerization-deficient 
mutant ΔN40 did not crosslink actin filaments strongly sup-
ported this hypothesis. AFAP-110 has also been reported to form 
a multimer and crosslink actin filaments (14, 34). Therefore, in 
terms of actin crosslinking, the function is likely to be conserved 
among AFAP family proteins. However, molecular mechanisms 
underlying the actin crosslinking appear to be different. Self-
association of AFAP-110 is mediated by at least two regions of 
AFAP-110, its PH1 domain and C-terminal LZIP motif (35). 
These observations are different from PI3KAP/XB130, which 
requires N-terminal 40 amino acids for multimerization and 
actin-crosslinking, as described above. Because this 40-amino-
acid region does not contain apparent domains or motifs that 
function in protein–protein interaction, the multimerization of 
PI3KAP/XB130 may occur through a novel mechanism.
In regard to the actin cytoskeleton, PI3KAP/XB130 has been 
reported to play an important role in lamellipodia formation 
and cell migration (16, 17, 36), but there were no reports show-
ing its involvement in other biological processes related to actin. 
At first, we tried to demonstrate the involvement of the actin-
binding ability of PI3KAP/XB130 in cell proliferation induced 
by TSH and IGF-I, because PI3KAP/XB130 is important for 
the signaling crosstalk as we previously reported (12). However, 
our preliminary data indicated that the effects of the ΔABR 
mutant were similar to wild-type PI3KAP/XB130 (unpublished 
data), suggesting that the actin-binding ability was not involved 
in the regulation of cell proliferation. Therefore, for the purpose 
of finding a novel process in which PI3KAP/XB130 is involved, 
we next verified effects of overexpression of this protein on 
endocytosis. Endocytosis is important for uptake of nutrients, 
regulation of signal transduction, and control of osmotic pres-
sure, and the actin cytoskeleton plays an indispensable role 
in these steps (37). In the present study, we demonstrated, for 
the first time, that PI3KAP/XB130 overexpression enhanced 
endocytosis using fluorescence-labeled dextran (Figure 6). We 
further performed functional studies using PI3KAP/XB130 
deletion mutants and found that most of the cells transfected 
with the ΔABR mutant lacking the actin-binding region 
showed dextran uptake similar to GFP-expressing control cells, 
suggesting that the actin-binding region is required for proper 
control of endocytosis by PI3KAP/XB130. However, we also 
observed that small number of cells incorporated high levels of 
dextran in ΔABR-expressing cells, and this fact indicates that 
PI3KAP/XB130 could enhance endocytosis through mecha-
nisms independent of its actin-binding ability. PI3KAP/XB130 
have several motifs and domains that can function in signal 
transduction, protein–protein interaction, or lipid-binding 
(11,  12, 23), and these motifs and domains may be involved 
in the mechanisms. In addition, loss-of-function analysis in 
a thyroid cell line raised a possibility that PI3KAP/XB130 is 
necessary for the regulation of endocytosis in endocrine cells 
(Figure 6). It is interesting that, in the thyroid, endocytic path-
ways play an important role in the control of thyroid hormone 
release (2), and further studies are necessary to uncover the 
relevance of PI3KAP/XB130-mediated endocytosis to endo-
crine cell physiology. Meanwhile, in cancer cells, endocytic 
pathways are important not only for the non-selective uptake of 
nutrients including amino acids (5) but also for cell migration 
and invasion through multiple ways such as integrin traffick-
ing and matrix metalloprotease transport (6). Thus, PI3KAP/
XB130-mediated endocytosis may be a clue to understand these 
processes in endocrine cancer cells.
In summary, our data clearly demonstrated that PI3KAP/
XB130 crosslinked actin filaments. Furthermore, its ability to 
crosslink actin filaments required both the N-terminal multimer-
izing region and the C-terminal novel actin-binding region. Taken 
together with the results that PI3KAP/XB130 has positive effects 
on endocytosis, we propose that PI3KAP/XB130 is a novel actin 
crosslinking protein and plays an important role in endocytosis.
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